المؤلفون: Ascierto, PA, Mandalà, M, Ferrucci, PF, Guidoboni, M, Rutkowski, P, Ferraresi, V, Arance, A, Guida, M, Maiello, E, Gogas, H, Richtig, E, Fierro, MT, Lebbè, C, Helgadottir, H, Queirolo, P, Spagnolo, F, Tucci, M, Del Vecchio, M, Gonzales Cao, M, Minisini, AM, De Placido, S, Sanmamed, MF, Mallardo, D, Curvietto, M, Melero, I, Palmieri, G, Grimaldi, AM, Giannarelli, D, Dummer, R, Chiarion Sileni, V

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(2):212-221

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:236049147

المؤلفون: Quaglino P, Ascierto PA, Consoli F, Queirolo P, Spagnolo F, Morelli MF, Berardi R, Chiarion-Sileni V, Tucci M, Troiani T, Melotti B, Rossi E, Mandala M, Rinaldi G, Marcon IG, Pizzuti M, Del Vecchio M

المصدر: Cancer Management and Research, Vol Volume 15, Pp 1271-1281 (2023)

مصطلحات موضوعية: braf mutation, dabrafenib, melanoma, real-world, trametinib, managed access program, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/characteristics-of-real-world-patients-with-high-risk-brafv600ek-mutat-peer-reviewed-fulltext-article-CMAR; https://doaj.org/toc/1179-1322

URL الوصول: https://doaj.org/article/61e573f959ce4c9193d56a436410e730

المؤلفون: Long, GV, Flaherty, KT, Stroyakovskiy, D, Gogas, H, Levchenko, E, de Braud, F, Larkin, J, Garbe, C, Jouary, T, Hauschild, A, Chiarion-Sileni, V, Lebbe, C, Mandala, M, Millward, M, Arance, A, Bondarenko, I, Haanen, JBAG, Hansson, J, Utikal, J, Ferraresi, V, Mohr, P, Probachai, V, Schadendorf, D, Nathan, P, Robert, C, Ribas, A, Davies, MA, Lane, SR, Legos, JJ, Mookerjee, B, Grob, JJ

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 28(7):1631-1639

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:136052661

المؤلفون: Faoro, L, Salizzato, V, Coppola, M, Carpanese, D, Fabozzi, A, Tondulli, L, Marconcini, R, Spagnolo, F, Del Bianco, P, Chiarion-Sileni, V, Piccin, L

المصدر: J Eur Acad Dermatol Venereol ; ISSN:1468-3083 ; Volume:39 ; Issue:1

Relation: https://doi.org/10.1111/jdv.20066; https://pubmed.ncbi.nlm.nih.gov/38712988; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664444/

الاتاحة: https://doi.org/10.1111/jdv.20066
https://pubmed.ncbi.nlm.nih.gov/38712988
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664444/

المؤلفون: Amaral, T, Ottaviano, M, Arance, A, Blank, C, Chiarion-Sileni, V, Donia, M, Dummer, R, Garbe, C, Gershenwald, J E, Gogas, H, Guckenberger, M, Haanen, J, Hamid, O, Hauschild, A, Höller, C, Lebbé, C, Lee, R J, Long, G V, Lorigan, P, Muñoz Couselo, E, Nathan, P, Robert, C, Romano, E, Schadendorf, D, Sondak, V, Suijkerbuijk, K P M, van Akkooi, A C J, Michelin, O, Ascierto, P A

المصدر: Ann Oncol ; ISSN:1569-8041 ; Volume:36 ; Issue:1

مصطلحات موضوعية: ESMO Clinical Practice Guideline, cutaneous melanoma, diagnosis, prognosis, risk assessment, treatment

Relation: https://doi.org/10.1016/j.annonc.2024.11.006; https://pubmed.ncbi.nlm.nih.gov/39550033

الاتاحة: https://doi.org/10.1016/j.annonc.2024.11.006
https://pubmed.ncbi.nlm.nih.gov/39550033

المؤلفون: Ascierto PA, Cioli E, Chiarion-Sileni V, Quaglino P, Spagnolo F, Guidoboni M, Del Vecchio M, Peris K, Queirolo P, Fioretto L, Caracò C, Paone M, Sorrentino A, Capone M, Giannarelli D, Ferrara G, Massi D, Trojaniello C.

المساهمون: Ascierto, Pa, Cioli, E, Chiarion-Sileni, V, Quaglino, P, Spagnolo, F, Guidoboni, M, Del Vecchio, M, Peris, K, Queirolo, P, Fioretto, L, Caracò, C, Paone, M, Sorrentino, A, Capone, M, Giannarelli, D, Ferrara, G, Massi, D, Trojaniello, C.

مصطلحات موضوعية: metastatic melanoma, cobimetinib, vemurafenib, atezolizumab, neoadjuvant therapy

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/36845751; info:eu-repo/semantics/altIdentifier/wos/WOS:000944656400001; volume:13; firstpage:1107307-1; lastpage:1107307-8; numberofpages:8; journal:FRONTIERS IN ONCOLOGY; https://hdl.handle.net/11392/2530089; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85148909857; https://www.frontiersin.org/articles/10.3389/fonc.2023.1107307/full

الاتاحة: https://hdl.handle.net/11392/2530089
https://doi.org/10.3389/fonc.2023.1107307
https://www.frontiersin.org/articles/10.3389/fonc.2023.1107307/full

المؤلفون: Wolchok, J. D.^1,2 jwolchok@med.cornell.edu, Chiarion-Sileni, V.³, Rutkowski, P.⁴, Cowey, C. L.⁵, Schadendorf, D.⁶, Wagstaff, J.^7,8, Queirolo, P.⁹, Dummer, R.¹⁰, Butler, M. O.¹¹, Hill, A. G.¹², Postow, M. A.^2,13, Gaudy-Márqueste, C.¹⁴, Lao, C. D.¹⁵, Walker, J.⁸, Márquez-Rodas, I.¹⁶, Haanen, J. B. A. G.¹⁷, Guidoboni, M.¹⁸, Maio, M.¹⁹, Carlino, M. S.^20,21,22, Sandhu, S.²³

المصدر: New England Journal of Medicine. 1/2/2025, Vol. 392 Issue 1, p11-22. 12p.

مصطلحات موضوعية: *PROGRAMMED death-ligand 1, *POISONS, *NIVOLUMAB, *OVERALL survival, *IPILIMUMAB

المؤلفون: Larkin, J, Del Vecchio, M, Mandala, M, Gogas, H, Arance, AM, Dalle, S, Cowey, CL, Schenker, M, Grob, J-J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, MO, Di Giacomo, AM, Middleton, MR, Lutzky, J, de la Cruz-Merino, L, Arenberger, P, Atkinson, V, Hill, AG, Fecher, LA, Millward, M, Nathan, PD, Khushalani, NI, Queirolo, P, Ritchings, C, Lobo, M, Askelson, M, Tang, H, Dolfi, S, Ascierto, PA, Weber, J

المساهمون: Larkin, James

جغرافية الموضوع: United States

وصف الملف: Print-Electronic; CCR-22-3145 -; application/pdf

Relation: 725906; Clinical Cancer Research, 2023, pp. CCR-22-3145 -; https://repository.icr.ac.uk/handle/internal/5881

الاتاحة: https://repository.icr.ac.uk/handle/internal/5881
https://doi.org/10.1158/1078-0432.CCR-22-3145

المؤلفون: Ascierto, PA, Lipson, EJ, Dummer, R, Larkin, J, Long, GV, Sanborn, RE, Chiarion-Sileni, V, Dréno, B, Dalle, S, Schadendorf, D, Callahan, MK, Nyakas, M, Atkinson, V, Gomez-Roca, CA, Yamazaki, N, Tawbi, HA, Sarkis, N, Warad, D, Dolfi, S, Mitra, P, Suryawanshi, S, Grob, J-J

المساهمون: Larkin, James

جغرافية الموضوع: United States

وصف الملف: Print-Electronic; application/pdf

Relation: Journal of Clinical Oncology, 2023, pp. JCO2202072 -; https://repository.icr.ac.uk/handle/internal/5779

الاتاحة: https://repository.icr.ac.uk/handle/internal/5779
https://doi.org/10.1200/JCO.22.02072

المؤلفون: Guida M., Bartolomeo N., Quaresmini D., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Valente M., Sciacovelli A. M., Chiarion Sileni V., Ascierto P. A., Stigliano L., Strippoli S.

المساهمون: Guida, M., Bartolomeo, N., Quaresmini, D., Quaglino, P., Madonna, G., Pigozzo, J., Di Giacomo, A. M., Minisini, A. M., Tucci, M., Spagnolo, F., Occelli, M., Ridolfi, L., Queirolo, P., De Risi, I., Valente, M., Sciacovelli, A. M., Chiarion Sileni, V., Ascierto, P. A., Stigliano, L., Strippoli, S.

مصطلحات موضوعية: Checkpoint inhibitor, Metastatic melanoma, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Blood Platelet, Human, Immunotherapy, Lymphocyte, Prognosi, Prospective Studie, Proto-Oncogene Proteins B-raf, Retrospective Studie, Melanoma, Neutrophils

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/35382857; info:eu-repo/semantics/altIdentifier/wos/WOS:000778499200004; volume:20; issue:1; firstpage:1; lastpage:15; numberofpages:15; journal:JOURNAL OF TRANSLATIONAL MEDICINE; https://hdl.handle.net/11365/1221041; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127719534; https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03359-x; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981693/

الاتاحة: https://hdl.handle.net/11365/1221041
https://doi.org/10.1186/s12967-022-03359-x
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03359-x
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981693/

المؤلفون: Larkin J., Weber J., Del Vecchio M., Gogas H., Arance A. M., Dalle S., Cowey C. L., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez-Rodas I., Butler M. O., Di Giacomo A. M., Middleton M. R., De la Cruz-Merino L., Arenberger P., Atkinson V., Hill A., Fecher L. A., Millward M., Khushalani N. I., Queirolo P., Long G. V., Lobo M., Askelson M., Ascierto P. A., Mandala M.

المساهمون: Larkin, J., Weber, J., Del Vecchio, M., Gogas, H., Arance, A. M., Dalle, S., Cowey, C. L., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez-Rodas, I., Butler, M. O., Di Giacomo, A. M., Middleton, M. R., De la Cruz-Merino, L., Arenberger, P., Atkinson, V., Hill, A., Fecher, L. A., Millward, M., Khushalani, N. I., Queirolo, P., Long, G. V., Lobo, M., Askelson, M., Ascierto, P. A., Mandala, M.

مصطلحات موضوعية: AJCC-8 criteria, Distant metastase, Ipilimumab, Melanoma adjuvant therapy, Nivolumab, Recurrence-free survival, Stage 3, Adjuvants, Immunologic, Human, Neoplasm Staging, Melanoma, Skin Neoplasms

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/35964471; info:eu-repo/semantics/altIdentifier/wos/WOS:000922633300002; volume:173; firstpage:285; lastpage:296; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11365/1221042; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85135858543; https://www.sciencedirect.com/science/article/pii/S0959804922003926

الاتاحة: https://hdl.handle.net/11365/1221042
https://doi.org/10.1016/j.ejca.2022.06.041
https://www.sciencedirect.com/science/article/pii/S0959804922003926

المؤلفون: Buja A., Rugge M., Trevisiol C., Zanovello A., Brazzale A. R., Zorzi M., Vecchiato A., Del, Fiore P., Tropea S., Chiarion-Sileni V., Rossi C. R., Mocellin S.

المساهمون: Buja, A., Rugge, M., Trevisiol, C., Zanovello, A., Brazzale, A. R., Zorzi, M., Vecchiato, A., Del , Fiore, P., Tropea, S., Chiarion-Sileni, V., Rossi, C. R., Mocellin, S.

Relation: info:eu-repo/semantics/altIdentifier/pmid/38709156; info:eu-repo/semantics/altIdentifier/wos/WOS:001320262000012; journal:JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY; https://hdl.handle.net/11577/3514123

الاتاحة: https://hdl.handle.net/11577/3514123
https://doi.org/10.1111/jdv.20077
https://onlinelibrary.wiley.com/doi/10.1111/jdv.20077

المؤلفون: Luke J. J., Ascierto P. A., Khattak M. A., De La Cruz Merino L., Del Vecchio M., Rutkowski P., Spagnolo F., Mackiewicz J., Chiarion-Sileni V., Kirkwood J. M., Robert C., Grob J. -J., De Galitiis F., Schadendorf D., Carlino M. S., Wu X. L., Fukunaga-Kalabis M., Krepler C., Eggermont A. M. M., Long G. V.

المساهمون: Luke, J. J., Ascierto, P. A., Khattak, M. A., De La Cruz Merino, L., Del Vecchio, M., Rutkowski, P., Spagnolo, F., Mackiewicz, J., Chiarion-Sileni, V., Kirkwood, J. M., Robert, C., Grob, J. -J., De Galitiis, F., Schadendorf, D., Carlino, M. S., Wu, X. L., Fukunaga-Kalabis, M., Krepler, C., Eggermont, A. M. M., Long, G. V.

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/38452313; volume:42; issue:14; firstpage:1619; lastpage:1624; numberofpages:6; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11567/1183315; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85191530838

الاتاحة: https://hdl.handle.net/11567/1183315
https://doi.org/10.1200/JCO.23.02355

المؤلفون: Wolchok, JD, Chiarion-Sileni, V, Gonzalez, R, Grob, J-J, Rutkowski, P, Lao, CD, Cowey, CL, Schadendorf, D, Wagstaff, J, Dummer, R, Ferrucci, PF, Smylie, M, Butler, MO, Hill, A, Marquez-Rodas, I, Haanen, JBAG, Guidoboni, M, Maio, M, Schoffski, P, Carlino, MS, Lebbe, C, McArthur, G, Ascierto, PA, Daniels, GA, Long, G, Bas, T, Ritchings, C, Larkin, J, Hodi, FS

Relation: Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Grob, J. -J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., Ferrucci, P. F., Smylie, M., Butler, M. O., Hill, A., Marquez-Rodas, I., Haanen, J. B. A. G., Guidoboni, M., Maio, M., Schoffski, P. ,. Hodi, F. S. (2022). Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. JOURNAL OF CLINICAL ONCOLOGY, 40 (2), pp.127-+. https://doi.org/10.1200/JCO.21.02229.; http://hdl.handle.net/11343/301620

الاتاحة: http://hdl.handle.net/11343/301620

المؤلفون: Eggermont, AM, Meshcheryakov, A, Atkinson, V, Blank, CU, Mandala, M, Long, GV, Barrow, C, Di Giacomo, AM, Fisher, R, Sandhu, S, Kudchadkar, R, Ortiz Romero, PL, Svane, IM, Larkin, J, Puig, S, Hersey, P, Quaglino, P, Queirolo, P, Stroyakovskiy, D, Bastholt, L, Mohr, P, Hernberg, M, Chiarion-Sileni, V, Strother, M, Hauschild, A, Yamazaki, N, van Akkooi, AC, Lorigan, P, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S, Robert, C

المساهمون: Larkin, James

مصطلحات موضوعية: Melanoma, Pembrolizumab, Salvage treatment, anti–PD-1

جغرافية الموضوع: England

وصف الملف: Print-Electronic; 168; application/pdf

Relation: S0959-8049(21)00620-1; European Journal of Cancer, 2021, 158 pp. 156 - 168; https://repository.icr.ac.uk/handle/internal/5291

الاتاحة: https://repository.icr.ac.uk/handle/internal/5291
https://doi.org/10.1016/j.ejca.2021.09.023

المؤلفون: Mandala, M, Larkin, J, Ascierto, PA, Del Vecchio, M, Gogas, H, Cowey, CL, Arance, A, Dalle, S, Schenker, M, Grob, J-J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, MO, Di Giacomo, AM, Lutzky, J, De La Cruz-Merino, L, Atkinson, V, Arenberger, P, Hill, A, Fecher, L, Millward, M, Khushalani, NI, de Pril, V, Lobo, M, Weber, J

المساهمون: Larkin, James

مصطلحات موضوعية: adjuvants, immunologic, immunotherapy, melanoma, programmed cell death 1 receptor, Aged, Disease-Free Survival, Female, Humans, Immune Checkpoint Inhibitors, Neoplasm Staging, Nivolumab, Treatment Outcome

جغرافية الموضوع: England

وصف الملف: Print; application/pdf

Relation: ARTN e003188; jitc-2021-003188; Journal for ImmunoTherapy of Cancer, 2021, 9 (8), pp. e003188 -; https://repository.icr.ac.uk/handle/internal/5285

الاتاحة: https://repository.icr.ac.uk/handle/internal/5285
https://doi.org/10.1136/jitc-2021-003188

المؤلفون: Del Vecchio, M., Atkinson, V.G., Ryll, B., Menzies, A.M., Aubin, F., Chiarion Sileni, V., Ferraresi, V., Lesimple, T., Rinaldi, G., Saiag, P., Robert, C., Dutriaux, C., Gogas, H.J., Demidov, L., Gupta, A., Banerjee, H., Sudhir, S., Miranda, F., Lau, M.R., Grob, J.J.

المصدر: Annals of Oncology ; volume 33, page S914 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2022.07.932
https://api.elsevier.com/content/article/PII:S0923753422027831?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753422027831?httpAccept=text/plain

المؤلفون: Ascierto PA, Mandalà M, Ferrucci PF, Rutkowski P, Guidoboni M, Arance Fernandez AM, Ferraresi V, Maiello E, Guida M, Del Vecchio M, Fierro MT, Queirolo P, Lebbè C, Helgadottir H, Melero I, Palmieri G, Giannarelli D, Grimaldi AM, Dummer R, Chiarion-Sileni V

المساهمون: Ascierto, Pa, Mandalà, M, Ferrucci, Pf, Rutkowski, P, Guidoboni, M, Arance Fernandez, Am, Ferraresi, V, Maiello, E, Guida, M, Del Vecchio, M, Fierro, Mt, Queirolo, P, Lebbè, C, Helgadottir, H, Melero, I, Palmieri, G, Giannarelli, D, Grimaldi, Am, Dummer, R, Chiarion-Sileni, V

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000573469102673; ispartofbook:Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020; ESMO Virtual Congress2020; volume:31; issue:S4; firstpage:S1173; lastpage:S1174; numberofpages:2; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11392/2530081; https://www.sciencedirect.com/science/article/pii/S0923753420423579

الاتاحة: https://hdl.handle.net/11392/2530081
https://doi.org/10.1016/j.annonc.2020.08.2275
https://www.sciencedirect.com/science/article/pii/S0923753420423579

المؤلفون: Guarneri V., Bassan F., Zagonel V., Milella M., Zaninelli M., Cattelan A. M., Vianello A., Gori S., Aprile G., Azzarello G., Chiari R., Favaretto A., Oliani C., Scola A., Pastorelli D., Mandara M., Zustovich F., Bernardi D., Chiarion-Sileni V., Morandi P., Toso S., Di Liso E., Ziampiri S., Caccese M., Zampiva I., Puccetti O., Celestino M., Dieci M. V., Conte P.

المساهمون: Guarneri, V., Bassan, F., Zagonel, V., Milella, M., Zaninelli, M., Cattelan, A. M., Vianello, A., Gori, S., Aprile, G., Azzarello, G., Chiari, R., Favaretto, A., Oliani, C., Scola, A., Pastorelli, D., Mandara, M., Zustovich, F., Bernardi, D., Chiarion-Sileni, V., Morandi, P., Toso, S., Di Liso, E., Ziampiri, S., Caccese, M., Zampiva, I., Puccetti, O., Celestino, M., Dieci, M. V., Conte, P.

مصطلحات موضوعية: Chemotherapy, COVID-19, Mortality, Patients with cancer, SARS-CoV-2 infection, Adult, Aged, 80 and over, Community Network, Disease Progression, Female, Hospital Mortality, Hospitalization, Human, Intensive Care Unit, Italy, Male, Middle Aged, Neoplasm, Pandemic, Prognosi, Registrie, SARS-CoV-2, Severity of Illness Index

Relation: info:eu-repo/semantics/altIdentifier/pmid/33647547; info:eu-repo/semantics/altIdentifier/wos/WOS:000631689400015; volume:147; firstpage:120; lastpage:127; numberofpages:8; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11577/3394806; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101651036

الاتاحة: http://hdl.handle.net/11577/3394806
https://doi.org/10.1016/j.ejca.2021.01.021

المؤلفون: Rastrelli M., Del Fiore P., Russo I., Tartaglia J., Dal Monico A., Cappellesso R., Nicole L., Piccin L., Fabozzi A., Biffoli B., Di Prata C., Ferrazzi B., Dall'Olmo L., Vecchiato A., Spina R., Russano F., Bezzon E., Cingarlini S., Mazzarotto R., Parisi A., Scarzello G., Pigozzo J., Brambullo T., Tropea S., Vindigni V., Bassetto F., Bertin D., Gregianin M., Dei Tos A. P., Cavallin F., Alaibac M., Chiarion-Sileni V., Mocellin S.

المساهمون: Rastrelli, M., Del Fiore, P., Russo, I., Tartaglia, J., Dal Monico, A., Cappellesso, R., Nicole, L., Piccin, L., Fabozzi, A., Biffoli, B., Di Prata, C., Ferrazzi, B., Dall'Olmo, L., Vecchiato, A., Spina, R., Russano, F., Bezzon, E., Cingarlini, S., Mazzarotto, R., Parisi, A., Scarzello, G., Pigozzo, J., Brambullo, T., Tropea, S., Vindigni, V., Bassetto, F., Bertin, D., Gregianin, M., Dei Tos, A. P., Cavallin, F., Alaibac, M., Chiarion-Sileni, V., Mocellin, S.

مصطلحات موضوعية: Merkel carcinoma, Merkel cell cancer, Merkel treatment strategie, non-melanoma skin cancer (NMSC), skin cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/34976795; info:eu-repo/semantics/altIdentifier/wos/WOS:000738466200001; volume:11; firstpage:737842; numberofpages:10; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/11577/3410860; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122104340; https://zenodo.org/record/5833513#.YdwgsVnSKUk

الاتاحة: http://hdl.handle.net/11577/3410860
https://doi.org/10.3389/fonc.2021.737842
https://zenodo.org/record/5833513#.YdwgsVnSKUk